Latus Bio, Inc. (Latus), a company advancing scalable genetic medicines for broad patient populations, today announced it ...
Agreement facilitates flexible, scalable automated industrialized production of rese-cel for many thousands of patients per year at a cost per ...
Zion Market Research has published a new research report titled “Biometrics As a Service (BaaS) in Healthcare Market By ...
OpenAI announced GPT-5.5, its latest AI model that is better at coding, using computers and pursuing deeper research ...
Drug discovery has long been defined by time, cost and uncertainty. Developing and optimising a single therapeutic antibody ...
Google unveiled Deep Research and Deep Research Max, new Gemini 3.1 Pro-powered AI agents that combine web search, ...
Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced continued progress within its artificial ...
A new study offers one of the most comprehensive global evaluations to date of how biochar can support climate-smart agriculture, providing critical ...
Biopharma is rebounding across rare disease, oncology and neuroscience. Here, Cytokinetics achieved a rare milestone: a first ...
The growing field of machine unlearning aims to make large language models forget harmful information without retraining them ...
Artificial intelligence (AI) agents are no longer neutral digital assistants but increasingly act as behavioral extensions of ...
Ticker Symbol to Change from TIVC to VBIO Effective April 28, 2026; Company Advancing Entolimod Toward BARDA Funding and Strategic National Stockpile Procurement While ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results